Stock Region Penny Picks
Stock Region Penny Picks
Stock Region Penny Picks Watchlist Newsletter
Stock Region Penny Picks Watchlist Newsletter - Tuesday, September 24th, 2024
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Disclaimer: The following information is provided for educational purposes only and should not be considered financial advice. Please conduct your own research and consult with financial professionals before making any investment decisions.
$TRNR - Interactive Strength Inc.
Interactive Strength Inc. has successfully passed EU compliance for their CLMBR product and will immediately begin fulfilling orders in Europe and the UK. This expansion marks a significant milestone in their growth strategy.
$DPRO - Draganfly Inc.
Draganfly has secured a military purchase order for its Commander 3XL drones, which will be used to aid logistics operations across various branches of the U.S. Department of Defense. This order highlights the growing demand for drone technology in critical applications.
$SLXN - Silexion Therapeutics
Silexion Therapeutics announced promising results from a Phase 2 trial of LODER™ for non-resectable pancreatic cancer. These findings may pave the way for further developments in treating this challenging condition.
$SEEL - Seelos Therapeutics
Seelos Therapeutics has entered into a Material Transfer Agreement with the U.S. Army's USAMMDA to evaluate SLS-002 for PTSD treatment. This partnership could enhance therapeutic options for military personnel and veterans.
$NRSN - NeuroSense Therapeutics
NeuroSense Therapeutics has been granted a key U.S. patent for its novel PrimeC formulation, which is a leading candidate for treating ALS and Alzheimer's. This patent strengthens their intellectual property portfolio.
$BNZI - Banzai Inc.
Banzai has announced a $24.8 million debt payoff and restructuring agreements, with participation from company insiders. This financial maneuver aims to strengthen the company’s balance sheet.
$CAPR - Capricor Therapeutics
Capricor Therapeutics intends to file a Biologics License Application for Deramiocel, targeting full approval for treating Duchenne Muscular Dystrophy Cardiomyopathy, a significant step in their therapeutic development pipeline.
$XHG - XChange TEC.INC
XChange TEC.INC has secured a $25.0 million committed equity facility with VG Master Fund SPC, providing the company with significant capital to support its strategic initiatives.
$FAAS - PayMate
PayMate has announced its intent to acquire DigiAsia, a move that could enhance its digital payment solutions and expand its market reach.
$BPTH - Bio-Path Holdings, Inc.
Bio-Path Holdings has been granted a US patent for P-ETHOXY nucleic acids used in liposomal formulations, potentially enhancing their anticancer and antiviral therapy tools.
$VTAK - Catheter Precision, Inc.
Catheter Precision has received a Chinese patent for its LockeT technology, which may open new opportunities in the global medical device market.
$LIPO - Lipella Pharmaceuticals
Lipella Pharmaceuticals reports early promising results in a Phase 2a trial of LP-310 for oral lichen planus, signifying potential therapeutic advancements.
$JFBR - Jeffs' Brands
Jeffs' Brands is experiencing accelerated growth in Europe following a successful launch of sales, signaling robust market acceptance.
$PRZO - ParaZero
ParaZero received a $187,000 purchase order for its advanced drone safety systems, moving closer to serial production and increasing its market footprint.
$KAPA - Kairos Pharma
Kairos Pharma has entered an agreement with PreCheck Health Services to develop biomarkers for identifying patients who respond well to ENV105, targeting cancer drug resistance in prostate and lung cancer patients. This collaboration stems from its recent IPO.
$MSGM - Le Mans Ultimate
Le Mans Ultimate has released an innovative co-op game mode, a save & load system, and the 2024 Pack 2 DLC, enhancing the gaming experience for its user base.
Disclaimer: This newsletter is intended for informational purposes only and does not constitute financial advice. Investors should perform their own due diligence and consult financial advisors as needed.
We are working endlessly to provide free insights on the stock market every day, and greatly appreciate those who are paid members supporting the development of the Stock Region mobile application. Stock Region offers daily stock and option signals, watchlists, earnings reports, technical and fundamental analysis reports, virtual meetings, learning opportunities, analyst upgrades and downgrades, catalyst reports, in-person events, and access to our private network of investors for paid members as an addition to being an early investor in Stock Region. We recommend all readers to urgently activate their membership before reaching full member capacity (500) to be eligible for the upcoming revenue distribution program. Memberships now available at https://stockregion.net